Evidence map›Paper›PMID 24914364›Full record

ReviewWorld journal of gastroenterology2014

Endoscopic therapy for early gastric cancer: standard techniques and recent advances in ESD.

Keiichiro Kume

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Early gastric cancer: A challenge in Western countries.World journal of gastroenterology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Endoscopic surgery - exploring the modalities.World journal of gastrointestinal surgery · 2015
    Review
  15. Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Keiichiro KumeKeiichiro Kume, Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan, School of Medicine, Kitakyusyu 807-8555, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The technique of endoscopic submucosal dissection (ESD) is now a well-known endoscopic therapy for early gastric cancer. ESD was introduced to resect large specimens of early gastric cancer in a single piece. ESD can provide precision of histologic diagnosis and can also reduce the recurrence rate. However, the drawback of ESD is its technical difficulty, and, consequently, it is associated with a high rate of complications, the need for advanced endoscopic techniques, and a lengthy procedure time. Various advances in the devices and techniques used for ESD have contributed to overcoming these drawbacks.

Indexed as

DissectionEndoscopesEndoscopyFibrinolytic AgentsGastric MucosaHumansPostoperative ComplicationsRisk FactorsStomach NeoplasmsSurgical InstrumentsTreatment OutcomeVenous ThrombosisFibrinolytic AgentsComplicationsEarly gastric cancerEndoscopic submucosal dissectionIndicationsRecent advancesStandard techniques

Identifiers

PMID24914364
PMCPMC4047328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.